top of page
Combined Power to Change the Game: RYBREVANT® + LAZCLUZE™ in First-Line Treatment of EGFR+* Locally Advanced or mNSCLC
Thu, Oct 24
|Grill 23 and Bar
Presented by Mark Socinski, MD Executive Medical Director AdventHealth Cancer Institute, Orlando, FL
Registration is closed
See other eventsbottom of page